Matches in Wikidata for { <http://www.wikidata.org/entity/Q95277923> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q95277923 description "artykuł naukowy opublikowany 18 maja 2020" @default.
- Q95277923 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95277923 description "scientific article published on 18 May 2020" @default.
- Q95277923 description "wetenschappelijk artikel" @default.
- Q95277923 description "наукова стаття, опублікована 18 травня 2020" @default.
- Q95277923 name "Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review" @default.
- Q95277923 name "Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review" @default.
- Q95277923 type Item @default.
- Q95277923 label "Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review" @default.
- Q95277923 label "Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review" @default.
- Q95277923 prefLabel "Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review" @default.
- Q95277923 prefLabel "Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review" @default.
- Q95277923 P1433 Q95277923-CD26190F-6D85-4092-8A18-66E645F18097 @default.
- Q95277923 P1476 Q95277923-59391EAD-8D78-4DC7-9206-5A2C628C550F @default.
- Q95277923 P2093 Q95277923-0C7AD176-18AC-4E77-932D-5B0D06984D2A @default.
- Q95277923 P2093 Q95277923-5D496826-5716-4672-A8E6-24CAC8524B42 @default.
- Q95277923 P2093 Q95277923-DF3B4FA0-1557-4E72-8433-FDB838FEE400 @default.
- Q95277923 P31 Q95277923-C8239E61-76D8-4D42-B5BB-8C601A704AC6 @default.
- Q95277923 P356 Q95277923-82C0937E-642E-4DD4-99FF-126A41935D61 @default.
- Q95277923 P50 Q95277923-8F11445D-D7E9-4684-BA10-7A4D9D5BAFF0 @default.
- Q95277923 P577 Q95277923-10F46379-3A0A-43AD-A684-3ADBEF4D13E6 @default.
- Q95277923 P698 Q95277923-7C4F68EA-581C-4544-918F-BE90BA158982 @default.
- Q95277923 P932 Q95277923-0E7BCF36-EAA9-454C-95B7-003B791A9391 @default.
- Q95277923 P356 1759-7714.13483 @default.
- Q95277923 P698 32421224 @default.
- Q95277923 P1433 Q26842004 @default.
- Q95277923 P1476 "Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review" @default.
- Q95277923 P2093 "Rui Kitadai" @default.
- Q95277923 P2093 "Shingo Kitagawa" @default.
- Q95277923 P2093 "Yukio Hosomi" @default.
- Q95277923 P31 Q13442814 @default.
- Q95277923 P356 "10.1111/1759-7714.13483" @default.
- Q95277923 P50 Q88099462 @default.
- Q95277923 P577 "2020-05-18T00:00:00Z" @default.
- Q95277923 P698 "32421224" @default.
- Q95277923 P932 "7327670" @default.